Women and older people under-represented in drug trials for heart disease

(University of Montreal) In the US, it's estimated the number of people aged 65 and older will double over the next 30 years. With the first baby boomers now turning 73, the demand for cardiac care is expected to skyrocket, not just in the US but elsewhere as well. Even though they have more cardiovascular problems, fewer women and people over 65 are recruited for randomized clinical trials than men and younger people.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news